Teladoc Health Inc (TDOC) Shares Bought by Baillie Gifford & Co.

Baillie Gifford & Co. boosted its stake in Teladoc Health Inc (NYSE:TDOC) by 5.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 740,042 shares of the health services provider’s stock after acquiring an additional 40,215 shares during the period. Baillie Gifford & Co.’s holdings in Teladoc Health were worth $36,683,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of the business. Essex Investment Management Co. LLC purchased a new position in shares of Teladoc Health during the 4th quarter valued at $5,802,000. Handelsinvest Investeringsforvaltning lifted its stake in shares of Teladoc Health by 153.9% during the 4th quarter. Handelsinvest Investeringsforvaltning now owns 50,775 shares of the health services provider’s stock valued at $2,517,000 after buying an additional 30,775 shares in the last quarter. Green Valley Investors LLC purchased a new position in shares of Teladoc Health during the 3rd quarter valued at $18,918,000. Wesbanco Bank Inc. lifted its stake in shares of Teladoc Health by 32.8% during the 4th quarter. Wesbanco Bank Inc. now owns 14,649 shares of the health services provider’s stock valued at $726,000 after buying an additional 3,614 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in shares of Teladoc Health by 11.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 525,875 shares of the health services provider’s stock valued at $45,410,000 after buying an additional 55,522 shares in the last quarter.

In other news, CEO Jason N. Gorevic sold 30,000 shares of the business’s stock in a transaction dated Wednesday, December 19th. The shares were sold at an average price of $49.55, for a total value of $1,486,500.00. Following the sale, the chief executive officer now directly owns 536,184 shares in the company, valued at approximately $26,567,917.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Michael Goldstein sold 20,500 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $63.40, for a total transaction of $1,299,700.00. Following the completion of the sale, the director now owns 21,418 shares in the company, valued at $1,357,901.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 127,493 shares of company stock worth $7,734,360. Insiders own 3.95% of the company’s stock.

Shares of NYSE TDOC opened at $60.94 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 8.53 and a current ratio of 8.53. The firm has a market capitalization of $4.27 billion, a price-to-earnings ratio of -42.32 and a beta of 1.44. Teladoc Health Inc has a 52-week low of $38.15 and a 52-week high of $89.05.

TDOC has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Teladoc Health from a “hold” rating to a “sell” rating in a research note on Friday, March 8th. Cantor Fitzgerald restated a “hold” rating and set a $83.00 target price on shares of Teladoc Health in a research note on Monday, January 7th. TheStreet upgraded shares of Teladoc Health from a “d+” rating to a “c” rating in a research note on Wednesday, February 20th. SunTrust Banks lifted their target price on shares of Teladoc Health to $75.00 and gave the company a “positive” rating in a research note on Monday, March 4th. Finally, Berenberg Bank initiated coverage on shares of Teladoc Health in a research note on Thursday, January 31st. They set a “buy” rating and a $80.00 target price on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $81.84.

WARNING: “Teladoc Health Inc (TDOC) Shares Bought by Baillie Gifford & Co.” was originally reported by Stock Observer and is the property of of Stock Observer. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.thestockobserver.com/2019/03/15/teladoc-health-inc-tdoc-shares-bought-by-baillie-gifford-co.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Why are percentage decliners important?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.